HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Helene Alexanderson Selected Research

Glucocorticoids

1/2022Factors Associated With Treatment Response in Patients With Idiopathic Inflammatory Myopathies: A Registry-Based Study.
10/2016Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Helene Alexanderson Research Topics

Disease

26Myositis (Idiopathic Inflammatory Myopathies)
01/2024 - 11/2002
22Dermatomyositis (Dermatopolymyositis)
01/2022 - 05/2004
20Polymyositis
01/2020 - 05/2004
10Inflammation (Inflammations)
01/2024 - 01/2003
5Arthritis (Polyarthritis)
01/2020 - 11/2002
4Inclusion Body Myositis
01/2018 - 10/2007
2Connective Tissue Diseases (Connective Tissue Disease)
01/2022 - 01/2020
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 01/2017
2Rheumatoid Arthritis
12/2017 - 01/2014
2Muscle Weakness
08/2013 - 02/2013
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022
1Deglutition Disorders (Dysphagia)
01/2022
1Exanthema (Rash)
01/2020
1Autoimmune Diseases (Autoimmune Disease)
01/2017
1Muscular Atrophy (Muscle Atrophy)
01/2017
1Hypertrophy
01/2016
1Systemic Scleroderma (Systemic Sclerosis)
02/2014
1Pain (Aches)
01/2014
1Fibrosis (Cirrhosis)
06/2012
1Chronic Disease (Chronic Diseases)
03/2009

Drug/Important Bio-Agent (IBA)

4ametantrone (HAQ)IBA
01/2021 - 11/2002
3AutoantibodiesIBA
01/2022 - 01/2019
3Proteins (Proteins, Gene)FDA Link
01/2017 - 05/2004
2Prostaglandins AIBA
01/2024 - 01/2014
2GlucocorticoidsIBA
01/2022 - 10/2016
2beta-cyclodextrin tetradecasulfate (CTDS)IBA
01/2022 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2020 - 05/2014
2Abatacept (Orencia)FDA Link
01/2019 - 01/2018
22-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
01/2018 - 11/2011
2Messenger RNA (mRNA)IBA
01/2017 - 11/2010
2InterleukinsIBA
05/2014 - 06/2012
2Oxygen (Dioxygen)IBA
11/2010 - 03/2009
2CreatineIBA
03/2009 - 05/2007
2CytokinesIBA
05/2004 - 01/2003
1Toll-Like Receptor 7IBA
10/2019
1LipidsIBA
01/2018
1FollistatinIBA
01/2018
1Protein Isoforms (Isoforms)IBA
01/2018
1MicroRNAs (MicroRNA)IBA
01/2017
1Antimicrobial Cationic PeptidesIBA
01/2017
1Interferon Type IIBA
01/2017
1InflammasomesIBA
10/2016
1Immunosuppressive Agents (Immunosuppressants)IBA
10/2016
1InterferonsIBA
10/2016
1Rituximab (Mabthera)FDA Link
11/2014
1AntibodiesIBA
11/2014
1Mi-2 antibodiesIBA
11/2014
1Lactic Acid (Lactate)FDA LinkGeneric
07/2014
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
05/2014
1HMGB1 Protein (HMG1)IBA
08/2013
1Leukotriene B4IBA
02/2013
1Interleukin-15 (Interleukin 15)IBA
06/2012
1Interleukin-15 Receptors (Interleukin 15 Receptor)IBA
06/2012
1amsonic acid (DAS)IBA
11/2011
1Intravenous Immunoglobulins (IVIG)FDA Link
10/2007
1CreatinineIBA
10/2007
1Phosphotransferases (Kinase)IBA
10/2007
1EnzymesIBA
08/2007
1Creatine Kinase (Creatine Phosphokinase)IBA
02/2006
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2004
1Prednisolone (Predate)FDA LinkGeneric
05/2004

Therapy/Procedure

6Resistance Training
01/2020 - 06/2007
6Therapeutics
11/2014 - 09/2003
3Endurance Training
02/2014 - 03/2005
2Activities of Daily Living (ADL)
12/2013 - 06/2012
1Exercise Therapy (Therapy, Exercise)
01/2020
1Treatment Delay
01/2018
1Injections
01/2018
1Acupuncture Therapy
12/2017
1Aftercare (After-Treatment)
10/2016
1Physical Therapy Modalities (Physical Therapy Technique)
11/2014